Verdonck K, González E, Henostroza G, Nabeta P, Llanos F, Cornejo H, Vanham G, Seas C, Gotuzzo E
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Int J Tuberc Lung Dis. 2007 Oct;11(10):1066-72.
Tuberculosis (TB) and human T-lymphotropic virus 1 (HTLV-1) are frequent in Peru. The prevalence of HTLV-1 among Peruvian TB patients is unknown.
To determine the prevalence of HTLV-1, HTLV-2 and the human immunodeficiency virus (HIV) in out-patients with TB and to compare HTLV-1-infected patients with seronegative patients.
Cross-sectional study including subjects aged 18-65 years diagnosed with smear-positive pulmonary TB at health centres in northern Lima from November 2004 to August 2005. HTLV and HIV screening was performed using enzyme-linked immunosorbent assay; HTLV-1 and HTLV-2 were confirmed using line immunoassay.
There were 311 participants with a median age of 29 years; 173 (56%) were men. HTLV-1 prevalence was 5.8% (18/311, 95%CI 3.2-8.4) and HIV prevalence was 1.3% (4/304, 95%CI 0.4-3.3). HTLV-2 was not diagnosed. In comparison with HIV- and HTLV-seronegative patients, HTLV-1-infected subjects were older (median age 44 vs. 28, P < 0.001) and were more likely to have been born in the southern Andes (OR 4.4, 95%CI 1.6-11.9). They were also more likely to report a history of TB deaths in the family (OR 5.4, 95%CI 1.7-16.8) and had more sputum smear results graded as 3+ (OR 4.1, 95%CI 1.5-11.2).
HTLV-1 screening among Peruvian TB patients is important. Because 3+ sputum smears are frequent and mortality is high among relatives, families of HTLV-1/TB-positive cases merit special attention.
结核病(TB)和人类嗜T淋巴细胞病毒1型(HTLV-1)在秘鲁较为常见。秘鲁结核病患者中HTLV-1的流行率尚不清楚。
确定结核病门诊患者中HTLV-1、HTLV-2和人类免疫缺陷病毒(HIV)的流行率,并比较HTLV-1感染患者与血清阴性患者。
横断面研究,纳入2004年11月至2005年8月在利马北部卫生中心诊断为涂片阳性肺结核的18至65岁受试者。采用酶联免疫吸附试验进行HTLV和HIV筛查;使用线性免疫测定法确认HTLV-1和HTLV-2。
共有311名参与者,中位年龄为29岁;173名(56%)为男性。HTLV-1流行率为5.8%(18/311,95%CI 3.2-8.4),HIV流行率为1.3%(4/304,95%CI 0.4-3.3)。未诊断出HTLV-2。与HIV和HTLV血清阴性患者相比,HTLV-1感染受试者年龄更大(中位年龄44岁对28岁,P<0.001),更有可能出生在安第斯山脉南部(OR 4.4,95%CI 1.6-11.9)。他们也更有可能报告家族中有结核病死亡史(OR 5.4,95%CI 1.7-16.8),且痰涂片结果评为3+的更多(OR 4.1,95%CI 1.5-11.2)。
对秘鲁结核病患者进行HTLV-1筛查很重要。由于痰涂片3+很常见且亲属死亡率高,HTLV-1/TB阳性病例的家庭值得特别关注。